This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

PRELIMINARY REPORT

MATTHEW T. MOORE, M.D.

Arch Intern Med. 1940;65(1):1-20.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The treatment of advanced multiple sclerosis with nicotinic acid and a combination of nicotinic acid and thiamin chloride has yielded promising results in cases in which the patients have failed to respond to therapies hitherto used. While complete remission has not been obtained, the use of the treatment suggested here has resulted in continued symptomatic improvement. The potential value of the suggested treatment may be judged in the light of prevailing conceptions of the etiology and treatment of multiple sclerosis.

From 1838, when Sir Robert Carswell, as cited by Putnam,¹ first described the pathology of multiple sclerosis, up to the present, the treatment of this disease has been entirely empiric. When one examines the diversity of remedial agents and methods employed, it becomes evident that the disarray is occasioned by complete ignorance of the etiology of the disease, coupled with the desire to find a remedy for one of the . . . [Full Text PDF of this Article]

Author Affiliations
PHILADELPHIA

From the Jewish Hospital and the John L. Eckel Neuropathological Laboratory, University of Pennsylvania Graduate School of Medicine.

Footnotes
Read before the Philadelphia Neurological Society, May 26, 1939.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?